Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Obesity (Silver Spring, Md.)
|
April 5, 2008
Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue
Mi-Jeong Lee, Susan K Fried, Steven S Mundt, et al.
Biochemistry
|
October 3, 1999
Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration
A Hermanowski-Vosatka, S S Mundt, J M Ayala, et al.
Biochemical and Biophysical Research Communications
|
August 4, 2001
ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5
S Patel, E M Thelander, M Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2011
Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome
Milana Maletic, Aaron Leeman, Michael Szymonifka, et al.
The Journal of Experimental Medicine
|
April 19, 2000
Infectious agents are not necessary for murine atherogenesis
S D Wright, C Burton, M Hernandez, et al.
Transgenic Research
|
November 1, 2011
Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue
Liwen Zhang, Yuchen Zhou, Amber Ying Zhu, et al.
Virus Genes
|
December 17, 2011
Comparative full genome analysis of four infectious laryngotracheitis virus (Gallid herpesvirus-1) virulent isolates from the United States
S J Spatz, J D Volkening, C L Keeler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 9, 2001
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
C P Sparrow, C A Burton, M Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2005
Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome
Xin Gu, Jasminka Dragovic, Gloria C Koo, et al.
Biochemical and Biophysical Research Communications
|
December 19, 2000
PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver
A Hermanowski-Vosatka, D Gerhold, S S Mundt, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Obesity (Silver Spring, Md.)
|
April 5, 2008
Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue
Mi-Jeong Lee, Susan K Fried, Steven S Mundt, et al.
Biochemistry
|
October 3, 1999
Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration
A Hermanowski-Vosatka, S S Mundt, J M Ayala, et al.
Biochemical and Biophysical Research Communications
|
August 4, 2001
ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5
S Patel, E M Thelander, M Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2011
Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome
Milana Maletic, Aaron Leeman, Michael Szymonifka, et al.
The Journal of Experimental Medicine
|
April 19, 2000
Infectious agents are not necessary for murine atherogenesis
S D Wright, C Burton, M Hernandez, et al.
Transgenic Research
|
November 1, 2011
Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue
Liwen Zhang, Yuchen Zhou, Amber Ying Zhu, et al.
Virus Genes
|
December 17, 2011
Comparative full genome analysis of four infectious laryngotracheitis virus (Gallid herpesvirus-1) virulent isolates from the United States
S J Spatz, J D Volkening, C L Keeler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 9, 2001
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
C P Sparrow, C A Burton, M Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2005
Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome
Xin Gu, Jasminka Dragovic, Gloria C Koo, et al.
Biochemical and Biophysical Research Communications
|
December 19, 2000
PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver
A Hermanowski-Vosatka, D Gerhold, S S Mundt, et al.
Page
of 4